Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Dynamic Allocation
  • Asset Class: Mixed Allocation
  • Geographic Focus: -

Centea Fund - Quality Stocks 9

+ Add to Watchlist

CENQUS9:BB

1,654.81 EUR

As of 00:59:30 ET on 03/16/2015.

Snapshot for Centea Fund - Quality Stocks 9 (CENQUS9)

Year To Date: +4.03% 3-Month: +5.66% 3-Year: +16.17% 52-Week Range: 1,347.95 - 1,654.81
1-Month: +0.91% 1-Year: +24.07% 5-Year: - Beta vs BEL20: -

Mutual Fund Chart for CENQUS9

No chart data available.
  • CENQUS9:BB 1,654.81
  • 1M
  • 1Y
Interactive CENQUS9 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CENQUS9

Centea Fund Quality Stocks 9 is a SICAV incorporated in Belgium. The Fund's objective is to repay investors the initial capital invested at maturity and a return based on the performance of a basket of 30 socially-responsible companies. The Fund invests its assets in bonds, debt and money-market instruments, other funds, deposits, liquidities and swaps.

Inception Date: 09-30-2011 Telephone: 32-2-429-5484 Tel
Managers: -
Web Site: www.kbcam.be

Fundamentals for CENQUS9

NAV (on 2015-03-16) 1,654.81
Assets (M) (on 2015-01-30) 2.30
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for CENQUS9

No dividends reported

Fees & Expenses for CENQUS9

Front Load 2.50
Back Load -
Current Mgmt Fee -
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CENQUS9

Filing Date: 12/31/2013
Name Position Value % of Total
Takeda Pharmaceutical Co Ltd 5,592 191,736 8.000%
Astellas Pharma Inc 115,366 191,736 8.000%
Kimberly-Clark Corp 2,382 167,769 7.000%
Consolidated Edison Inc 4,374 167,769 7.000%
Altria Group Inc 6,314 167,769 7.000%
Taiwan Semiconductor Manufactu 47,751 119,835 5.000%
Koninklijke KPN NV 51,563 119,835 5.000%
Eisai Co Ltd 4,418 119,835 5.000%
Roche Holding AG 606 119,835 5.000%
Unilever PLC 4,168 119,835 5.000%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil